Imuran and Neupogen drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Imuran (azathioprine) and Neupogen (filgrastim). Common drug interactions include nasal ulcer among females and abdominal pain upper among males.

The phase IV clinical study analyzes what interactions people have when they take Imuran and Neupogen. It is created by eHealthMe based on reports of 40 people who take the same drugs from the FDA, and is updated regularly.

What is Imuran?

Imuran has active ingredients of azathioprine. It is often used in crohn's disease. eHealthMe is studying from 34,915 Imuran users. Check the latest studies of Imuran.

What is Neupogen?

Neupogen has active ingredients of filgrastim. It is often used in agranulocytosis. eHealthMe is studying from 23,898 Neupogen users. Check the latest studies of Neupogen.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 30, 2026

40 people who take Imuran and Neupogen together, and have interactions are studied.

Imuran and Neupogen drug interactions.

What are the common drug interactions of Imuran and Neupogen, by gender? *:

female:

  1. Nasal ulcer (ulcer of nose)
  2. Nausea (feeling of having an urge to vomit)
  3. Osteitis (a general term for inflammation of bone)
  4. Palpitations (feelings or sensations that your heart is pounding or racing)
  5. Peripheral swelling
  6. Psoriasis (immune-mediated disease that affects the skin)
  7. Vaginal haemorrhage (vaginal bleeding)
  8. Vomiting
  9. Abdominal distension
  10. Acute febrile neutrophilic dermatosis (skin disease characterized by the sudden onset of fever, leukocytosis, and tender)

male:

  1. Abdominal pain upper
  2. Fatigue (feeling of tiredness)
  3. Nausea (feeling of having an urge to vomit)
  4. Pruritus (severe itching of the skin)
  5. Rash erythematous (redness of the skin)
  6. Rectal haemorrhage (bleeding from anus)
  7. Lung neoplasm malignant (cancer tumour of lung)
  8. Fall
  9. Nasopharyngitis (inflammation of the nasopharynx)
  10. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)

What are the common drug interactions of Imuran and Neupogen, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Pyrexia (fever)
  2. Acute sinusitis
  3. Anaemia (lack of blood)
  4. Aortic arteriosclerosis (hardening of the aortic arteries)
  5. Aortic valve incompetence
  6. Aortic valve sclerosis (narrowing of the aortic valve)
  7. Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
  8. Ascites (accumulation of fluid in the abdominal cavity)
  9. Asthenia (weakness)
  10. Atelectasis (partial or complete collapse of the lung)

20-29:

  1. Abdominal pain upper
  2. Alanine aminotransferase increased
  3. Aspartate aminotransferase increased
  4. Bk virus infection
  5. Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
  6. Cerebral aspergillosis (pus collection with swelling in brain)
  7. Chronic graft versus host disease (immune cells attack the host's body cells after transplant)
  8. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  9. Cytomegalovirus antigen positive
  10. Diarrhoea

30-39:

  1. Ageusia (loss of taste functions of the tongue)
  2. Dysgeusia (disorder of the sense of taste)

40-49:

  1. Chronic kidney disease
  2. Nephrogenic anaemia (anaemia due to kidney disease)
  3. Renal failure (kidney dysfunction)
  4. Acute febrile neutrophilic dermatosis (skin disease characterized by the sudden onset of fever, leukocytosis, and tender)
  5. Arthralgia (joint pain)
  6. Asthma
  7. Back pain
  8. Contusion (a type of hematoma of tissue in which capillaries)
  9. Decreased immune responsiveness
  10. Fatigue (feeling of tiredness)

50-59:

  1. Rash
  2. Rash erythematous (redness of the skin)
  3. Raynaud's phenomenon (discoloration of the fingers, toes, and occasionally other areas)
  4. Respiratory tract infection
  5. Sinusitis (inflammation of sinus)
  6. Spinal osteoarthritis (joint cartilage loss in spine)
  7. Arthralgia (joint pain)
  8. Asthma
  9. Back pain
  10. Contusion (a type of hematoma of tissue in which capillaries)

60+:

  1. Arthralgia (joint pain)
  2. Fatigue (feeling of tiredness)
  3. Nausea (feeling of having an urge to vomit)
  4. Pruritus (severe itching of the skin)
  5. Pyrexia (fever)
  6. Rash erythematous (redness of the skin)
  7. Haemorrhoids (a swollen vein or group of veins in the region of the anus)
  8. Nasopharyngitis (inflammation of the nasopharynx)
  9. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  10. Asthenopia (eyestrain-tiredness of the eyes caused by prolonged close work by a person with an uncorrected vision problem)

What are the existing conditions these people have? *

  1. High Blood Pressure: 4 people, 10.00%
  2. Anaemia (lack of blood): 4 people, 10.00%
  3. Rickets (softening of bones): 3 people, 7.50%
  4. Leukopenia (less number of white blood cells in blood): 3 people, 7.50%
  5. Indigestion: 3 people, 7.50%
  6. Gout (uric acid crystals building up in the body): 3 people, 7.50%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 7.50%
  8. Depression: 3 people, 7.50%
  9. Calcium Deficiency (lack of calcium): 3 people, 7.50%
  10. Acute Kidney Failure: 3 people, 7.50%

* Approximation only. Some reports may have incomplete information.

Do you take Imuran and Neupogen?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Imuran and Neupogen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Imuran:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Neupogen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Imuran and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Neupogen and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on azathioprine and filgrastim (the active ingredients of Imuran and Neupogen, respectively), and Imuran and Neupogen (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: